Despite years of research, conventional therapies are highly invasive or non-specific and there are currently no treatment options to prevent relapse for cancer (20 million new cancer cases in 2025, with over 5000 new cancer survivors daily in the Western world). Immunetune is developing personalized DNA vaccins (NeoVAC) to empower cancer patients’ immune defenses to fight cancer and to equip them with durable protection to prevent recurrence.